Latest Breaking News On - Emma holian - Page 1 : vimarsana.com

When used as biomarker, microRNA can help predict which breast cancer patients are more likely to see their cancer come back

When used as biomarker, microRNA can help predict which breast cancer patients are more likely to see their cancer come back
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesRepublic of irelandNicola millerAoifej loweryMatthewg daveyMaxwell pagangaAndrew mcguireRonanm waldronMaire caitlin caseyMacconm keaneJohn newellEmma holianMichaelj kerinAilbhem mcdermottHelenm heneghanUniversity of galway

Potential of Precision Genomics Established in Cancer Treatment

Read Time: Researchers at NUI Galway have identified genomic signatures in women developing the most common type of breast cancer that can be associated with long-term survival. The NUI Galway team analysed the genomes of breast cancer patients to look for associations with survival rates using advanced statistical techniques. Carried out by Lydia King during her studies in NUI Galwayâs MSc in Biomedical Genomics programme, the research has been published in the international journal PLOS ONE. Early detection by national screening programmes and timely treatment for patients diagnosed with âluminalâ types of breast cancer have resulted in excellent prognoses with survival rates of over 80% within five years of treatment. The challenge of long-term survival however is not as well understood and studies have shown that more than half of all recurrences for luminal breast cancers takes place after this time point. Identifying patients most likely to suffer relapses w

United kingdomEmma holianAndrew flausLydia kingCambridge universityMolecular taxonomy of breast cancer international consortiumSchool of natural sciencesGalway school of mathematicsBiomedical genomicsMolecular taxonomyBreast cancer international consortiumApplied mathematicsNatural sciencesProgramme directorஒன்றுபட்டது கிஂக்டம்எம்மா ஹோலியன்

Scientists identify genomic signatures of long-term survival in luminal breast cancer patients

Scientists identify genomic signatures of long-term survival in luminal breast cancer patients Researchers at NUI Galway have identified genomic signatures in women developing the most common type of breast cancer that can be associated with long-term survival. The NUI Galway team analyzed the genomes of breast cancer patients to look for associations with survival rates using advanced statistical techniques. Carried out by Lydia King during her studies in NUI Galway s MSc in Biomedical Genomics programme, the research has been published in the international journal PLOS ONE. Early detection by national screening programmes and timely treatment for patients diagnosed with luminal types of breast cancer have resulted in excellent prognoses with survival rates of over 80% within five years of treatment. The challenge of long-term survival however is not as well understood and studies have shown that more than half of all recurrences for luminal breast cancers takes place after t

United kingdomEmma holianAndrew flausLydia kingEmily hendersonCambridge universityMolecular taxonomy of breast cancer international consortiumSchool of natural sciencesGalway school of mathematicsScience foundation irelandBiomedical genomicsMolecular taxonomyBreast cancer international consortiumNatural sciencesAaron golden senior authorProgramme director